New Year Bumper Sale @ Rs. 1 X
Lavrez XL is an allopathic medicine The correct dosage of Lavrez XL depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Lavrez XL is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Lavrez XL safe for pregnant women?
Pregnant women may experience moderate side effects from Lavrez XL. It is best to stop taking Lavrez XL immediately and inform your doctor if you notice any discomfort.
Is the use of Lavrez XL safe during breastfeeding?
Lavrez XL may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Lavrez XL, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Lavrez XL.
What is the effect of Lavrez XL on the Kidneys?
Very few cases of side effects of Lavrez XL on kidney have been reported.
What is the effect of Lavrez XL on the Liver?
Lavrez XL can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Lavrez XL on the Heart?
Side effects of Lavrez XL rarely affect the heart.
Lavrez XL should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Lavrez XL unless your doctor advises you to do so -
Is this Lavrez XL habit forming or addictive?
Forming a habit of Lavrez XL has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Lavrez XL since it does not cause drowsiness.
Is it safe?
Yes, but take Lavrez XL only as per medical advice.
Is it able to treat mental disorders?
No, the use of Lavrez XL in mental disorders is not effective.
Interaction between Food and Lavrez XL
There isn't any research available on the side effects of taking Lavrez XL with food.
Interaction between Alcohol and Lavrez XL
Taking alcohol with Lavrez XL can be dangerous.
Yes, Lavrez XL can be taken with paracetamol. No harmful drug-drug interactions have been reported between them. However, if you feel any discomfort after taking them together then discuss with your doctor.
Yes, Lavrez XL can be taken with phenylephrine. No harmful drug interactions have been reported between them. However, if you feel any discomfort or unpleasant effects after taking this drug inform your doctor immediately.
There is no fixed rule to take this Medicine], this drug can be taken during any time of the day as per doctor's instructions. However, taking it in the evening is more advisable because this drug can cause sleepiness and drowsiness. Activities such as driving and operating heavy machinery should be avoided after taking this Lavrez XL to prevent accidents and injuries.
Lavrez XL is not a pain-killer. It belongs to the class of drug called antihistamines. This drug primarily helps in arresting the allergy and relieving symptoms of allergies such as runny nose, non-stop sneezing, and red-watery itchy eyes.
Yes, [medicine] can cause stomach upset. It is a common side effect of this drug. Please inform your doctor if you are experiencing stomach upset after taking this medicine.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Allegra® (fexofenadine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 163,166
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 566
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)